Effect of atorvastatin on clinical outcomes in hospitalized patients with acute respiratory distress syndrome

ZHANG Kaixuan; YAO Zhiyuan; LIAO Zhaomin; WU Wei; JIANG Guijun; ZHANG Zhaocai; SONG Zhenju; ZHAN Liying; XIA Wenfang

doi:10.14188/j.1671-8852.2024.0519

您当前的位置：

首页 >

文章列表页 >

Effect of atorvastatin on clinical outcomes in hospitalized patients with acute respiratory distress syndrome

更新时间：2026-11-05

- Effect of atorvastatin on clinical outcomes in hospitalized patients with acute respiratory distress syndrome
- Medical Journal of Wuhan University Vol. 46, Issue 2, Pages: 194-198(2025)
- 作者机构：
  
  1.武汉大学人民医院重症医学科湖北武汉 430060
  2.浙江大学医学院附属第二医院重症医学科/浙江省急危重症临床医学研究中心浙江杭州 310009
  3.复旦大学附属中山医院急诊科/复旦大学应急救援与急危重症研究所上海 200032
- 作者简介：
- 基金信息：
- DOI：10.14188/j.1671-8852.2024.0519
  CLC： R563.9
- Received：10 July 2024，
  
  Published：25 February 2025
- 稿件说明：
移动端阅览
张凯旋,姚智远,廖兆敏等.急性呼吸窘迫综合征住院患者使用阿托伐他汀对临床结局的影响[J].武汉大学学报（医学版）,2025,46(02):194-198.

ZHANG Kaixuan,YAO Zhiyuan,LIAO Zhaomin,et al.Effect of atorvastatin on clinical outcomes in hospitalized patients with acute respiratory distress syndrome[J].Medical Journal of Wuhan University,2025,46(02):194-198.
张凯旋,姚智远,廖兆敏等.急性呼吸窘迫综合征住院患者使用阿托伐他汀对临床结局的影响[J].武汉大学学报（医学版）,2025,46(02):194-198. DOI： 10.14188/j.1671-8852.2024.0519.

ZHANG Kaixuan,YAO Zhiyuan,LIAO Zhaomin,et al.Effect of atorvastatin on clinical outcomes in hospitalized patients with acute respiratory distress syndrome[J].Medical Journal of Wuhan University,2025,46(02):194-198. DOI： 10.14188/j.1671-8852.2024.0519.

摘要

目的

探讨急性呼吸窘迫综合征（ARDS）住院患者使用阿托伐他汀对于炎症指标、凝血功能及预后的影响。

方法

本研究采用回顾性队列研究，在武汉大学人民医院ARDS专病数据库中选取了256名入住ICU并且诊断为ARDS的患者，其中128名使用了阿托伐他汀治疗（阿托伐他汀组），128名未使用（对照组），观察阿托伐他汀用药前后患者炎症指标及凝血功能指标PT和APTT的变化，并且评估使用阿托伐他汀对患者预后的影响。

结果

阿托伐他汀组28 d死亡率与对照组相比显著降低（

0.05），无呼吸机天数和ICU住院时间无显著差异。阿托伐他汀组用药前后炎症指标无明显改善（

0.05）；PT和APTT延长（

0.05）。

结论

ARDS患者使用阿托伐他汀可改善凝血功能，并能降低其死亡率，提示阿托伐他汀可改善ARDS患者的临床结局，可作为ARDS患者的一种治疗选择。

Abstract

Objective

To investigate the impact of atorvastatin on inflammatory markers

coagulation function

and prognosis in hospitalized patients with acute respiratory distress syndrome （ARDS）.

Methods

We conducted a retrospective cohort study using the ARDS⁃specific database from Renmin Hospital of Wuhan University. A total of 256 ICU patients diagnosed with ARDS were selected

inclunding 128 patients who received atorvastatin treatment （atorvastatin group） and 128 did not (control group). Changes in inflammatory markers and coagulation function (PT and APTT) were observed before and after atorvastatin administration and its impact on patient prognosis was assessed.

Results

In the atorvastatin group

the 28⁃day mortality rate was significantly lower than that in the control group (

0.05). However

there was no significant improvement in inflammatory markers after atorvastatin treatment (

0.05); coagulation indices

and APTT

in the atorvastatin group were prolonged after treatment (

0.05).

Conclusion

The use of atorvastatin in ARDS patients can improve coagulation function and reduce mortality rates

suggesting that atorvastatin may improve clinical outcomes and could be considered a therapeutic option for ARDS patients.

关键词

Keywords

references

Matthay M A , Arabi Y , Arroliga A C , et al . A new global definition of acute respiratory distress syndrome [J ] . Am J Respir Crit Care Med , 2024 , 209 ( 1 ): 37 ⁃ 47 .

Villar J . What is the acute respiratory distress syndrome? [J ] . Respir Care , 2011 , 56 ( 10 ): 1539 ⁃ 1545 .

Bellani G , Laffey J G , Pham T , et al . Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries [J ] . JAMA , 2016 , 315 ( 8 ): 788 ⁃ 800 .

Meyer N J , Gattinoni L , Calfee C S . Acute respiratory distress syndrome [J ] . Lancet , 2021 , 398 ( 10300 ): 622 ⁃ 637 .

Schenk P , Spiel A O , Hüttinger F , et al . Can simvastatin reduce COPD exacerbations? A randomised double⁃blind controlled study [J ] . Eur Respir J , 2021 , 58 ( 1 ): 2001798 .

Tong F , Dong B , Chai R K , et al . Simvastatin nanoparticles attenuated intestinal ischemia/reperfusion injury by downregulating BMP4/COX⁃2 pathway in rats [J ] . Int J Nanomedicine , 2017 , 12 : 2477 ⁃ 2488 .

Chen W J , Pan J Y . Anatomical and pathological observation and analysis of SARS and COVID⁃19: Microthrombosis is the main cause of death [J ] . Biol Proced Online , 2021 , 23 ( 1 ): 4 .

Prével R , Dupont A , Labrouche⁃Colomer S , et al . Plasma markers of neutrophil extracellular trap are linked to survival but not to pulmonary embolism in COVID⁃19⁃related ARDS patients [J ] . Front Immunol , 2022 , 13 : 851497 .

Manitsopoulos N , Orfanos S E , Kotanidou A , et al . Inhibition of HMGCoA reductase by simvastatin protects mice from injurious mechanical ventilation [J ] . Respir Res , 2015 , 16 ( 1 ): 24 .

National Heart L , Truwit J D , Bernard G R , et al . Rosuvastatin for sepsis⁃associated acute respiratory distress syndrome [J ] . N Engl J Med , 2014 , 370 ( 23 ): 2191 ⁃ 2200 .

Calfee C S , Delucchi K L , Sinha P , et al . Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: Secondary analysis of a randomised controlled trial [J ] . Lancet Respir Med , 2018 , 6 ( 9 ): 691 ⁃ 698 .

Corsini A , Bellosta S , Baetta R , et al . New insights into the pharmacodynamic and pharmacokinetic properties of statins [J ] . Pharmacol Ther , 1999 , 84 ( 3 ): 413 ⁃ 428 .

Glynn R J , Danielson E , Fonseca F A H , et al . A randomized trial of rosuvastatin in the prevention of venous thromboembolism [J ] . N Engl J Med , 2009 , 360 ( 18 ): 1851 ⁃ 1861 .

Liu C , Shen M C , Tan W L W , et al . Statins improve endothelial function via suppression of epigenetic⁃driven EndMT [J ] . Nat Cardiovasc Res , 2023 , 2 ( 5 ): 467 ⁃ 485 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Role of N⁃acetylcysteine in the treatment of acute respiratory distress syndrome

Shenfu injection combined therapy alleviates sepsis‐induced coagulopathy：A randomized controlled study

Association of serum magnesium levels with 30‐day mortality in patients with acute respiratory distress syndrome

Meta⁃analysis of the effect of glucocorticoids on the prognosis of adult patients with acute respiratory distress syndrome

Standardized recommendations for orthogonal experimental validation of genetic variants identified in clinical next⁃generation sequencing reports

Related Author

ZHANG Zhaocai

LI Xiaoyan

PENG Wei

CHEN Qianqian

SUN Jiale

LIU Zhou

WANG Lu

MAO Changshu

Related Institution

Dept. of Critical Care Medicine， The Second Affiliated Hospital Zhejiang University School of Medicine & Zhejiang Province Clinical Research Center for Emergency and Critical Care Medicine

Department of Critical Care Medicine, Renmin Hospital of Wuhan University

Department of Critical Care Medicine, People's Hospital of Macheng City

Department of Critical Care Medicine, Tongcheng County Hospital

Department of Intensive Care Unit, Renmin Hospital of Wuhan University

AI问答

⁰